Whilst CHIP is associated with an increased risk for cardiovascular disease (CVD) [71] or haematological malignancies [38], a study focussing on the 10-year survival of LLI did not observe a higher mortality for carriers of CHIP-driver mutations [29]. This evidence concerns the gene STUB1 and cardiovascular disorder.